BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 24474685)

  • 1. A small molecule inhibitor of monoubiquitinated Proliferating Cell Nuclear Antigen (PCNA) inhibits repair of interstrand DNA cross-link, enhances DNA double strand break, and sensitizes cancer cells to cisplatin.
    Inoue A; Kikuchi S; Hishiki A; Shao Y; Heath R; Evison BJ; Actis M; Canman CE; Hashimoto H; Fujii N
    J Biol Chem; 2014 Mar; 289(10):7109-7120. PubMed ID: 24474685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small molecule inhibitors of PCNA/PIP-box interaction suppress translesion DNA synthesis.
    Actis M; Inoue A; Evison B; Perry S; Punchihewa C; Fujii N
    Bioorg Med Chem; 2013 Apr; 21(7):1972-7. PubMed ID: 23395113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of small molecule proliferating cell nuclear antigen (PCNA) inhibitor that disrupts interactions with PIP-box proteins and inhibits DNA replication.
    Punchihewa C; Inoue A; Hishiki A; Fujikawa Y; Connelly M; Evison B; Shao Y; Heath R; Kuraoka I; Rodrigues P; Hashimoto H; Kawanishi M; Sato M; Yagi T; Fujii N
    J Biol Chem; 2012 Apr; 287(17):14289-300. PubMed ID: 22383522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-inhibition of Pol η and ATR sensitizes cisplatin-resistant non-small cell lung cancer cells to cisplatin by impeding DNA damage repair.
    Li XQ; Ren J; Chen P; Chen YJ; Wu M; Wu Y; Chen K; Li J
    Acta Pharmacol Sin; 2018 Aug; 39(8):1359-1372. PubMed ID: 29849128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis for novel interactions between human translesion synthesis polymerases and proliferating cell nuclear antigen.
    Hishiki A; Hashimoto H; Hanafusa T; Kamei K; Ohashi E; Shimizu T; Ohmori H; Sato M
    J Biol Chem; 2009 Apr; 284(16):10552-60. PubMed ID: 19208623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential roles for DNA polymerases eta, zeta, and REV1 in lesion bypass of intrastrand versus interstrand DNA cross-links.
    Hicks JK; Chute CL; Paulsen MT; Ragland RL; Howlett NG; Guéranger Q; Glover TW; Canman CE
    Mol Cell Biol; 2010 Mar; 30(5):1217-30. PubMed ID: 20028736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. REV3 and REV1 play major roles in recombination-independent repair of DNA interstrand cross-links mediated by monoubiquitinated proliferating cell nuclear antigen (PCNA).
    Shen X; Jun S; O'Neal LE; Sonoda E; Bemark M; Sale JE; Li L
    J Biol Chem; 2006 May; 281(20):13869-72. PubMed ID: 16571727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RAD6B is a major mediator of triple negative breast cancer cisplatin resistance: Regulation of translesion synthesis/Fanconi anemia crosstalk and BRCA1 independence.
    Haynes B; Gajan A; Nangia-Makker P; Shekhar MP
    Biochim Biophys Acta Mol Basis Dis; 2020 Jan; 1866(1):165561. PubMed ID: 31639439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of budding yeast Rad18 in repair of HO-induced double-strand breaks.
    Hirano Y; Reddy J; Sugimoto K
    DNA Repair (Amst); 2009 Jan; 8(1):51-9. PubMed ID: 18824138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small-molecules that bind to the ubiquitin-binding motif of REV1 inhibit REV1 interaction with K164-monoubiquitinated PCNA and suppress DNA damage tolerance.
    Vanarotti M; Evison BJ; Actis ML; Inoue A; McDonald ET; Shao Y; Heath RJ; Fujii N
    Bioorg Med Chem; 2018 May; 26(9):2345-2353. PubMed ID: 29598900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PCNA inhibition enhances the cytotoxicity of β-lapachone in NQO1-Positive cancer cells by augmentation of oxidative stress-induced DNA damage.
    Su X; Wang J; Jiang L; Chen Y; Lu T; Mendonca MS; Huang X
    Cancer Lett; 2021 Oct; 519():304-314. PubMed ID: 34329742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A site-selective, irreversible inhibitor of the DNA replication auxiliary factor proliferating cell nuclear antigen (PCNA).
    Evison BJ; Actis ML; Wu SZ; Shao Y; Heath RJ; Yang L; Fujii N
    Bioorg Med Chem; 2014 Nov; 22(22):6333-43. PubMed ID: 25438756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of monoubiquitinated PCNA and implications for translesion synthesis and DNA polymerase exchange.
    Freudenthal BD; Gakhar L; Ramaswamy S; Washington MT
    Nat Struct Mol Biol; 2010 Apr; 17(4):479-84. PubMed ID: 20305653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NMR mapping of PCNA interaction with translesion synthesis DNA polymerase Rev1 mediated by Rev1-BRCT domain.
    Pustovalova Y; Maciejewski MW; Korzhnev DM
    J Mol Biol; 2013 Sep; 425(17):3091-105. PubMed ID: 23747975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Additive effects of a small molecular PCNA inhibitor PCNA-I1S and DNA damaging agents on growth inhibition and DNA damage in prostate and lung cancer cells.
    Lu S; Dong Z
    PLoS One; 2019; 14(10):e0223894. PubMed ID: 31600334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A role for polymerase eta in the cellular tolerance to cisplatin-induced damage.
    Albertella MR; Green CM; Lehmann AR; O'Connor MJ
    Cancer Res; 2005 Nov; 65(21):9799-806. PubMed ID: 16267001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Proliferating Cell Nuclear Antigen (PCNA)-interacting Protein (PIP) Motif of DNA Polymerase η Mediates Its Interaction with the C-terminal Domain of Rev1.
    Boehm EM; Powers KT; Kondratick CM; Spies M; Houtman JC; Washington MT
    J Biol Chem; 2016 Apr; 291(16):8735-44. PubMed ID: 26903512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of translesion synthesis DNA polymerase eta by monoubiquitination.
    Bienko M; Green CM; Sabbioneda S; Crosetto N; Matic I; Hibbert RG; Begovic T; Niimi A; Mann M; Lehmann AR; Dikic I
    Mol Cell; 2010 Feb; 37(3):396-407. PubMed ID: 20159558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The herpes simplex virus 1 UL36USP deubiquitinase suppresses DNA repair in host cells via deubiquitination of proliferating cell nuclear antigen.
    Dong X; Guan J; Zheng C; Zheng X
    J Biol Chem; 2017 May; 292(20):8472-8483. PubMed ID: 28348081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Division of labor within the DNA damage tolerance system reveals non-epistatic and clinically actionable targets for precision cancer medicine.
    Spanjaard A; Shah R; de Groot D; Buoninfante OA; Morris B; Lieftink C; Pritchard C; Zürcher LM; Ormel S; Catsman JJI; de Korte-Grimmerink R; Siteur B; Proost N; Boadum T; van de Ven M; Song JY; Kreft M; van den Berk PCM; Beijersbergen RL; Jacobs H
    Nucleic Acids Res; 2022 Jul; 50(13):7420-7435. PubMed ID: 35819193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.